Tag: Biognosys Proteomics,Biognosys’ HRM technology,GeneStrat,NSCLC,Press Releases,Proteomic Signatures,Veristrat,blood-based cancer test,cancer diagnostics,oncology
-
Biodesix Adds Biognosys’ Proteomics Technology To Its Diagnostic Development Capabilities; Collaboration Enables Protein Identification Within Proteomic Signatures
Biodesix, Inc., a molecular diagnostics company that discovers and commercializes blood-based diagnostic tests to improve outcomes for patients with cancer, and Biognosys AG, a leader in next-gen proteomics, today announced that Biodesix® will begin offering Biognosys’ HRM technology as part of its companion diagnostic development capabilities to develop novel protein assays for the oncology…